Clinical Trials Search Results

A randomized phase III trial studying the best dose of apixaban and how well it works in preventing secondary cancer related blood clots in cancer patients who have completed anticoagulation therapy.

A phase III trial in metastatic untreated renal cell cancer.

This precision medicine cancer treatment trial seeks to determine whether treating cancer based on specific genetic changes is effective.

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug.